No disclosed counterparties: DHR, MLAB.
| Stage | DHR | % of rev | MLAB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $60M | 100.00% | DHR ×108.98 |
| Gross profit | $3.8B | 58.54% | $39M | 64.87% | MLAB +6.3pp |
| Operating income | $1.2B | 19.00% | $7M | 11.69% | DHR +7.3pp |
| Pre-tax income | $1.1B | 17.27% | $4M | 7.24% | DHR +10.0pp |
| Net income | $1.2B | 18.84% | $3M | 4.71% | DHR +14.1pp |
| Stage | DHR | MLAB | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $60M100.00% | DHR ×108.98 |
| Gross profit | 58.54%$3.8B | 64.87%$39M | MLAB +6.3pp |
| Operating income | 19.00%$1.2B | 11.69%$7M | DHR +7.3pp |
| Pre-tax income | 17.27%$1.1B | 7.24%$4M | DHR +10.0pp |
| Net income |
| 18.84%$1.2B |
| 4.71%$3M |
| DHR +14.1pp |